Abstract:BACKGROUND & OBJECTIVE:Angiogenesis plays an important role in growth and metastasis of tumors. Vascular endothelial growth factor (VEGF) is considered as a fundamental regulator for angiogenesis. This study was to construct a recombinant T7 phage vaccine expressing xenogenic VEGF on the capsid, and test its inhibitory effect on Lewis lung cancer cells in mice.METHODS:VEGF gene was cloned by reverse transcription-polymerase chain reaction (RT-PCR) from human lung cancer tissues, and inserted into phage using T7 Select10-3b kit to construct T7 Select10-3b_VEGF vaccine. The titer of prepared phage reached 1x10(13) pfu/ml. C57BL/6J mice were randomly divided into 3 groups: T7 Select10-3b_VEGF vaccine group (T7-VEGF), T7 phage (T7) group, normal saline (NS) group (10 mice/group). Each mouse was injected with Freundos adjuvant mixed with 1x10(12) pfu/200 microl T7 Select10-3b_VEGF, or T7, or normal saline once a week for 4 weeks. Lewis lung carcinoma model (LL/2) was established in C57BL/6J mice after 4-week immunization. Tumor growth and mouse's physical status were observed during immunization. Tumor weight and serum level of specific anti-VEGF antibody were measured by enzyme-linked immunosorbent assay (ELISA). Microvessel density (MVD) of tumors was detected by immunohistochemistry 14 days after the inoculation of tumor cells.RESULTS:Tumor weight of T7-VEGF vaccine group,T7 group, and NS group were (0.543+/-0.259)g, (0.982+/-0.359)g, (1.169+/-0.460)g, respectively. Tumor weight of T7-VEGF vaccine group was significantly lower than that of NS group (P<0.01). Serum anti-VEGF antibody level in T7-VEGF vaccine group was 1:1,000. MVD was significantly lower in T7-VEGF vaccine group than in NS group (8.5+/-0.8 vs 18.5+/-1.6, P<0.05). MVD in T7 group was 16.4+/-1.3.CONCLUSION:Recombinant T7 phage vaccine expressing xenogenic VEGF can break immunologic tolerance against self-VEGF and inhibit the growth of Lewis lung cancer cells.

Experimental Study of Breast Cancer Treatment with Recombinant EGFR Antisense Adenovirus

Experimental Research on Radiosensitization Mechanisms of the Recombinant Antisense Adenovirus for EGFR in Human Breast Cancer Cells

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

The Construction and Characterization of a Novel Adenovirus Vector of Artificial Microrna Targeting EGFR.

AN ANTI-TUMOR RESEARCH OF RECOMBINANT PHAGE VACCINE EXPRESSED XENOGENIC EGFR

Adenovirus-mediated Inhibitor Kappab Gene Transfer Improves the Chemosensitivity to Anticancer Drugs in Human Lung Cancer in Vitro and in Vivo.

Inhibition of Tumor Growth by Recombinant Adenovirus Containing Human Lactoferrin Through Inducing Tumor Cell Apoptosis in Mice Bearing Emt6 Breast Cancer

[Antitumor Effect of Recombinant T7 Phage Vaccine Expressing Xenogenic Vascular Endothelial Growth Factor on Lewis Lung Cancer in Mice].

Effect of VEGF-C Interfering on the Lymphangiogenesis of a Mouse Model Bearing Human Colon Cancer

Antitumor Efficacy of SLPI Promoter-Controlled Expression of Artificial microRNA Targeting EGFR in a Squamous Cell Carcinoma Cell Line

Construction of Recombinant Adenovirus Carrying Kringle 5 Gene and Effects on the Survival of Pulmonary Carcinoma Bearing Mice

[Therapeutic Effect of Adenovirus-Mediated Apoptin Gene Transfer Combined with ADM and CDDP on Hepatocellular Carcinoma in Mice].

The Oncolytic Adenovirus Ad-E1A in the Gene Therapy of Mouse Ascitic Hepatoma in Vivo and Its Effect on Immune Function

Influence of TK adenovirus vector regulated by hypoxia and radiation on the growth and apoptosis of breast cancer cells

Adenovirus 5 E1a-Mediated Gene Therapy for Human Ovarian Cancer Cells in Vitro and in Vivo

[Inhibition of mouse Lewis lung cancer via intravenous administration of recombinant mouse sFlt1 adenovirus].

The Curative Effects and Side Effects of Recombinant Human Adenovirus P53 on Transplanted Gastric Cancer Cells in Nude Mice

Tumor-suppressing Effect of Recombinant Adenovirus Encoding LRIG1 Gene Driven by Survivin Promoter in Nude Mice Heterotransplanted Models of Human Bladder Cancer

Combination of Adenovirus-Mediated TRAIL Gene Therapy and EGFR Target Therapy in NSCLC Cell

A comparative study of the ability of recombinant oncolytic adenovirus, doxorubicin and tamoxifen to inhibit the proliferation of breast cancer cells

Baculovirus Mediated Experimental Research on Targeted Egr1-Kringle 5 Gene Radiotherapy in Lung Adenocarcinoma